FXR agonist 4 is a small molecule activator of the Farnesoid X receptor (FXR) with an EC50 of 1.05 µM. It has demonstrated efficacy in preclinical models, improving metabolic parameters such as hyperlipidemia, hepatic steatosis, and insulin resistance in diet-induced obese mice, supporting its research application in NAFLD/NASH.
Molekulargewicht:
373.92
Formel:
C21H28ClN3O
Target-Kategorie:
FXR,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
